体外診断(IVD)パッケージングの世界市場2021-2026:成長・動向・新型コロナの影響・市場予測

◆英語タイトル:In-vitro Diagnostics (IVD) Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
◆商品コード:MOR21CH422
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2021年1月
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,250 ⇒換算¥484,500見積依頼/購入/質問フォーム
Team User(5名利用)USD4,750 ⇒換算¥541,500見積依頼/購入/質問フォーム
Corporate License(法人利用)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMordor Intelligence社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Mordor Intelligence社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、世界の体外診断(IVD)パッケージング市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(ボトル、バイアル、チューブ、クロージャ、その他製品種類)分析、エンドユーザー別(病院、研究所、学術機関、その他)分析、地域別分析、競争状況、投資分析、市場機会・将来動向などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の体外診断(IVD)パッケージング市場規模:製品別(ボトル、バイアル、チューブ、クロージャ、その他製品種類)
・世界の体外診断(IVD)パッケージング市場規模:エンドユーザー別(病院、研究所、学術機関、その他)
・世界の体外診断(IVD)パッケージング市場規模:地域別
・競争状況
・投資分析
・市場機会・将来動向
【レポートの概要】

The In-vitro Diagnostics (IVD) Packaging market was valued at USD 7.10 billion in 2020 and is expected to reach USD 9.23 billion by 2026, at a CAGR of 4.5% over the forecast period (2021 – 2026). The global in vitro diagnostics packaging market is booming mainly due to technological advancements, enhanced diagnostic tools, and increased availability of over-the-counter tests.

- The rapidly-rising practice of self-testing by the people, an increasing number of point-of-care testing, increased government expenditures on healthcare, growing awareness of personalized medicine, and the increasing number of chronic diseases are some of the major factors boosting the growth of the in vitro diagnostics (IVD) packaging market.
- The importance of IVD packaging is increasing in the healthcare sector, owing to the demand for faster diagnosis time and increased volume of samples obtained by the automation devices. This has resulted in the increased usage of IVD devices in hospitals.
- Other contributing factors boosting the growth of the market include the pressure from the governments and industries across the world, to comply with the set regulations, due to the increasing demand for integrated healthcare systems. For instance, the FDA uses a risk-based regulatory scheme for medical devices (including IVDs).

Key Market Trends

Laboratories Segment to Witness High Growth

- As the hospitals and laboratories are some of the major consumers of in vitro diagnostic devices, the increasing revenues of these sectors are also expected to develop the market for IVD packaging across the world.
- With the shift from the legacy systems to the commercial solutions favored by the laboratories, the market is expected to grow further as they provide a flexible and reliable method to manage data, resources, and workflows.
- Many governments across the world are also regulating policies for laboratories having IVDs. For instance, in May 2018, Australia’s Therapeutic Goods Administration (TGA) unveiled guidance for laboratories to meet in vitro diagnostics (IVD) regulatory requirements.
- Moreover, the ongoing shift toward personalized medical devices is expected to create a demand for IVD devices. Also, the innovations in IVD devices are likely to accelerate the demand for IVD packaging during the forecast period.

Asia-Pacific to Witness High Growth

- The Chinese government is increasing China’s healthcare expenditure, primarily to focus on public health. With the increasing number of hospitals in China, it is justifying the investment in public health initiative, which is driving the market in this region.
- Moreover, Japan has faced the challenges of shrinking and aging population for several years. The latest population estimate by the Health, Labor, and Welfare Ministry, released in December 2018, points to the rapid decline of Japan’s population with fewer births. The number of babies born in the country, in 2018, is estimated at 921,000, which is 25,000 less than the previous year and falling short of one million for the third year in a row. These circumstances in the country have accelerated healthcare spending in the region.
- India is also considered as a lucrative market for generic R&D activities and manufacturing of pharmaceuticals, owing to its strong capabilities across the value chain. Moreover, India’s competitive advantage also resides in the magnified success rate of Indian companies in getting the Abbreviated New Drug Application (ANDA) approvals, which is boosting the market growth.

Competitive Landscape

The in vitro diagnostics (IVD) packaging market is competitive due to the presence of many players running their business in both the domestic and international markets. The market is moderately concentrated with the major players adopting strategies, like product innovation and mergers and acquisitions. Some of the major players in the market are Amcor Limited, Aptargroup Incorporated, and Thermo Fisher Scientific Incorporated, among others.

- June 2019 – Amcor announced the successful completion of its acquisition of Bemis Company Inc. The combined company will now operate as Amcor Plc (Amcor). The acquisition of Bemis brings additional scale, capabilities, and footprint that will strengthen Amcor’s industry-leading value proposition.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

【レポートの目次】

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Growing Demand for Tubes
4.3.2 Increasing Number of Point-of-care Tests
4.4 Market Restraints
4.4.1 Environmental Concerns Related to Raw Materials for Packaging
4.5 Industry Attractiveness – Porter’s Five Force Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Bottles
5.1.2 Vials
5.1.3 Tubes
5.1.4 Closures
5.1.5 Other Product Types
5.2 By End User
5.2.1 Hospitals
5.2.2 Laboratories
5.2.3 Academic Institutes
5.2.4 Other End Users
5.3 Geography
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Latin America
5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amcor Limited
6.1.2 Aptargroup Incorporated
6.1.3 Corning Incorporated
6.1.4 Greiner Holding AG
6.1.5 Thermo Fisher Scientific Incorporated
6.1.6 COMAR, LLC.
6.1.7 WS Packaging Group
6.1.8 DWK Life Sciences

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[体外診断(IVD)パッケージングの世界市場2021-2026:成長・動向・新型コロナの影響・市場予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆